Emergence of carbapenem non-susceptible Campylobacter coli after long-term treatment against recurrent bacteremia in a patient with X-linked agammaglobulinemia

23Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

Abstract

We herein report a case of recurrent Campylobacter coli bacteremia in a 37-year-old Japanese man with X-linked agammaglobulinemia (XLA). The patient experienced seven episodes of C. coli bacteremia over one year, with an erythematous rash intermittently emerged on the lower limbs. Although hospitalization for intravenous treatment was repeatedly recommended, he obstinately declined it. Following long-term oral antibiotic treatment with tebipenem and faropenem for the persistent infection, C. coli showed elevated minimum in-hibitory concentrations to meropenem, a key drug for severe campylobacteriosis. Physicians should note that the overuse of antibiotics can lead to the emergence of carbapenem-non-susceptible Campylobacter strains.

Cite

CITATION STYLE

APA

Hagiya, H., Kimura, K., Nishi, I., Yoshida, H., Yamamoto, N., Akeda, Y., & Tomono, K. (2018). Emergence of carbapenem non-susceptible Campylobacter coli after long-term treatment against recurrent bacteremia in a patient with X-linked agammaglobulinemia. Internal Medicine, 57(14), 2077–2080. https://doi.org/10.2169/internalmedicine.0312-17

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free